These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22581216)

  • 1. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
    de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
    Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
    Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
    Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
    J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
    Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
    Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
    Klein Haneveld MJ; van Treijen MJC; Pieterman CRC; Dekkers OM; van de Ven A; de Herder WW; Zandee WT; Drent ML; Bisschop PH; Havekes B; Vriens MR; Verrijn Stuart AA; Valk GD; van Leeuwaarde RS
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3515-3525. PubMed ID: 34333645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
    van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
    Chevalier B; Coppin L; Romanet P; Cuny T; Maïza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1482-e1493. PubMed ID: 38288531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.